We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fast Track Total Hip Replacement Surgery Effective and Safe

By HospiMedica International staff writers
Posted on 13 Jul 2011
Healthy patients who undergo total hip replacement (THR) can be fast tracked to be discharged in two days compared with the standard three to six days, according to a new study.

Researchers at the Hospital for Special Surgery (HSS; New York, NY, USA) conducted a prospective study to compare the outcomes of patients undergoing THR between 2004 and 2008. More...
One cohort of 149 patients underwent THR with a fast track protocol; the other cohort of 134 patients underwent THR followed by the hospital's traditional clinical pathway, which aimed to discharge patients at four days at that time. Patients in the two cohorts were matched for age, sex, body mass index (BMI), and comorbidities. Patients were excluded if they had inflammatory arthritis, complex THR, and medical comorbidities such as a history of a myocardial infarction (MI), pulmonary embolism (PE), or deep vein thrombosis (DVT), as all patients in the study were discharged with aspirin.

The results showed that 58% of the fast track cohort was discharged within two days of a THR, and 73% were discharged within three days; the average discharge time was 2.6 days in the fast track cohort and 4.1 in the traditional cohort. Although five patients were readmitted from the fast track group, compared with only one from the traditional group, no differences in the rates of overall complications between the two groups was found. Postoperative pain, nausea, and dizziness interfered with physical therapy and, as a result, were the main reasons for an unsuccessful two-day discharge. At one year, there were no differences in complications, readmissions, or reoperation between the two cohorts. The study was published early online on July 2, 2011, in HSS Journal.

“Before this study, we were uncertain how safe it would be to discharge patients within two days after a total hip replacement, but based on this study, we now know that it is safe,” said first author Lawrence Gulotta, MD, an orthopedic surgeon at HSS. “This is something that can help improve health care costs and provide better care for our patients by keeping them out of the hospital.”

The “Fast Track” protocol encourages patients to get up and move around earlier and more frequently. Hospital-based epidural pain relief is stopped earlier and patients are given aspirin to prevent blood clots. In addition, arrangements are made for a physical therapist to work with the patient at home after discharge.

Related Links:

Hospital for Special Surgery




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.